Persimmon (Diospyros) contains polyphenol compounds (proanthocyanidin polymers). The content of polyphenol compounds in persimmon extract was estimated to be 27% by the acidified vanillin method. The effect of persimmon extract on a two-stage model of carcinogenesis which consisted of initiation by 7,12-dimethylbenz [a]-anthracene (DMBA) and promotion by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) was investigated. Formation of mouse skin papillomas was remarkably inhibited by persimmon extract. In in vitro experiments, it was found that the [3H]TPA binding to mouse skin particulates and the activity of ornithine decarboxylase (ODC), a marker enzyme of tumor promotion, were inhibited dose-dependently by the persimmon extract, and that DPPH radicals and active oxygens (OH, O2-) were scavenged by persimmon extract. These findings suggest that the suppression of the skin carcinogenesis results from the inhibition of [3H]TPA binding to mouse skin particulate and ODC activity and the scavenging of active oxygens by the persimmon extract.
No takes yet. Share an insight, caveat, or question.
Achiwa et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: